Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Contingent Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹925 Cr₹1,019 Cr₹89 Cr₹48 Cr₹83 Cr

What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?

The latest Contingent Liabilities ratio of MANKIND PHARMA is ₹925 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹925 Cr
Mar2025₹1,019 Cr
Mar2024₹89 Cr
Mar2023₹48 Cr
Mar2022₹83 Cr

How is Contingent Liabilities of MANKIND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2026 ₹925 Cr
-9.29
Mar2025 ₹1,019 Cr
1,045.33
Mar2024 ₹89 Cr
85.77
Mar2023 ₹48 Cr
-41.97
Mar2022 ₹83 Cr -

Compare Contingent Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹105,108.5 Cr 3.4% 6.6% -4.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr -0.3% -3.1% 12.8% Stock Analytics
DIVIS LABORATORIES ₹251,531.0 Cr -1.3% 2.2% 57.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,957.0 Cr -1.3% -2.4% 33.3% Stock Analytics
CIPLA ₹111,729.0 Cr 0.2% -2.5% -9.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,335.0 Cr 3.3% 6.1% -6.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

3.4%

6.6%

-4.8%

SENSEX

-2.7%

-5.7%

-11.7%


You may also like the below Video Courses